Status:
RECRUITING
MRI-Guided Cryoablation for Focal Native Prostate Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Primary Malignant Neoplasm of Prostate (Diagnosis)
Eligibility:
MALE
30-100 years
Brief Summary
The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the ...
Detailed Description
The purpose of this study is to evaluate MR-guided cryoablation of biopsy proven prostate tumors using the Galil MRI-compatible cryoablation system. The system has been approved by the United States F...
Eligibility Criteria
Inclusion
- Patients with "biopsy proven" Gleason7 prostate cancer referred to Urology and/or Interventional Radiology for treatment
- Surgery and/or Radiation is not a desirable alternative therapy at the time of enrollment
- Tumor size is \< 2 cm at its largest diameter
- Tumor does not encompass the rectal wall or external urethral sphincter
- Patient is able to undergo MRI
Exclusion
- •
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04797039
Start Date
December 1 2020
End Date
December 1 2030
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905